We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Monday
May 18
17:00 - 18:00
T2
Breast cancer 5
Liesbeth Boersma, The Netherlands;
Pedro Meireles, Portugal
Mini-Orals
Clinical
17:00 - 18:00
Pathological downstaging and molecular biomarkers after pre-operative radiosurgery in early-stage breast cancer: The CRYSTAL study
Marco Lucarelli, Italy
-4880
17:00 - 18:00
Acute radiation side effects of proton versus photon therapy following surgery for early breast cancer or DCIS: a sub-study of the DBCG PROTON Trial
Kristine Wiborg Høgsbjerg, Denmark
-3959
17:00 - 18:00
Management and outcomes of locally recurrent breast cancer: A population-based analysis in Ontario, Canada
Danielle Rodin, Canada
-3622
17:00 - 18:00
Stereotactic Ablative Radiotherapy for Oligoprogressive Breast Cancer: A Systematic Review and Meta-analysis of Prospective Clinical Trials
Vivian Tan, Canada
-3640
17:00 - 18:00
High-dose volume predicts fat necrosis after post-operative single fraction stereotactic partial breast irradiation (S-PBI) in a phase II trial
Giuseppe Facondo, Italy
-2446
17:00 - 18:00
Can breathing training improve DIBH in radiotherapy for left-sided breast cancer? – Preliminary results of the B-REST trial
Rebecca Moser, Germany
-3373
17:00 - 18:00
Carbon-ion radiotherapy as a non-surgical treatment for early-stage breast cancer: long-term follow-up of a phase I/II trial (jRCTs032180153)
Noriyuki Okonogi, Japan
-451
17:00 - 18:00
Intraoperative radiotherapy as partial breast irradiation in early breast cancer: Results of  the national registry  of Spain (RIOMA trial)
Xavier Sanz Latiesas, Spain
-1118